Original Research Article I Volume 5 I Issue 1 I 2017

Role of Hypertonic Saline Nebulization Therapy in Patients with Early Acute Respiratory Distress Syndrome

Tayseer Mohamed Zaytoun, Amr Hassan Dahroug and Hala Mohamed Abdella

Biolife. 5(1), pp 74-84

DOI:https://doi.org/10.5281/zenodo.7360210

Abstract:

Acute respiratory syndrome (ARDS) is a life threatening condition with high mortality rates. It is characterized by inflammation of the lung parenchyma leading to impaired gas exchange with concomitant systemic release of inflammatory mediators causing protracted inflammation, increased vascular permeability, increased permeability of alveolar epithelial cells, extravasation of plasma and leucocyte infiltration, and frequently resulting in multiple organ failure. Since inflammation is thought to contribute to the pathogenesis of ARDS, it is rational to explore modulating therapies for this inflammation, provided the adverse effect of such treatment is not excessive.

Keywords:

Acute respiratory distress syndrome (ARDS), hypertonic saline, hypoxic index.

References:

  1. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342(18):1301-8.
  2. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2:319–23.
  3. Wark PA, McDonald V. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev 2000(2):Cd001506.
  4.  Reeves EP, Williamson M, O’Neill SJ, Greally PMcElvaney NG. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 2011; 183:1517–23.
  5. Angle N, Hoyt DB, Coimbra R, Liu F, Herdon-Remelius C, Loomis W, et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock 1998; 9:164–70.
  6. Middleton PG, Pollard KA, Wheatley JR. Hypertonic saline alters ion transport across the human airway epithelium. Eur Respir J 2000; 17:195–9.
  7. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151:1075–82.
  8. Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 2003;123(2):481-7.
  9. Taube C, Holz O, Mucke M, Jorres RA, Magnussen H. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(10 Pt 1):1810-5
  10. Angle NHoyt DBCoimbra RLiu FHerdon-Remelius CLoomis W, et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock 1998; 9:164–70.
  11. Gonzalez RJMoore EECiesla DJNeto JRBiffl WLSilliman CC. Hyperosmolality abrogates neutrophil cytotoxicity provoked by post-shock mesenteric lymph. Shock 2002; 18:29–32.
  12. Powers KAWoo JKhadaroo RGPapia GKapus ARotstein OD. Hypertonic resuscitation of hemorrhagic shock upregulates the anti-inflammatory response by alveolar macrophages. Surgery 2003; 134:312–8....

Article Dates:

Received: 6 January 2017; Accepted: 27 February 2017; Published: 5 March 2017

How To Cite:

Tayseer Mohamed Zaytoun, Amr Hassan Dahroug, & Hala Mohamed Abdella. (2022). Role of Hypertonic Saline Nebulization Therapy in Patients with Early Acute Respiratory Distress Syndrome. Biolife, 5(1), 74–84. https://doi.org/10.5281/zenodo.7360210

Download Full Paper: PDF

Logo


Logo